The following compounds were approved by the FDA as New Molecular Entities (NMEs) in August 2015.
| Drug name || Active Ingredient || Company |
| Varubi || Rolapitant || Tesaro Inc. |
| Xuriden || Uridine Triacetate || Wellstat Therapeutics Corp |
| Vraylar || Cariprazine || Forest Labs LLC |
| Lonsurf || Trifluridine;Tipiracil || Taiho Oncology Inc |
| Tresiba || Insulin Degludec || Novo Nordisk Inc |
You can find further information on the FDA website